Dimensional Fund Advisors LP Has $119.93 Million Stake in Teleflex Incorporated $TFX

Key Points

• Dimensional Fund Advisors LP increased its stake in Teleflex Incorporated by 69.5% during Q1, owning approximately 1.96% of the company, worth around $119.9 million.
• Teleflex reported $3.73 earnings per share for the last quarter, surpassing analysts' expectations, and the company had a revenue growth of 4.2% year-over-year.
• The company announced a quarterly dividend of $0.34 per share, representing an annual yield of 1.1%, with a payout ratio of 32.00%.

Dimensional Fund Advisors LP raised its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 69.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 867,864 shares of the medical technology company's stock after purchasing an additional 355,720 shares during the quarter. Dimensional Fund Advisors LP owned 1.96% of Teleflex worth $119,927,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB grew its position in shares of Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after buying an additional 100 shares in the last quarter. Banque Cantonale Vaudoise acquired a new stake in Teleflex during the first quarter valued at approximately $27,000. Costello Asset Management INC bought a new position in Teleflex during the 1st quarter worth approximately $28,000. Whipplewood Advisors LLC grew its position in shares of Teleflex by 7,700.0% in the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after acquiring an additional 231 shares in the last quarter. Finally, Allworth Financial LP raised its position in shares of Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock valued at $34,000 after acquiring an additional 212 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Wall Street Zen raised shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Wells Fargo & Company cut their target price on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Truist Financial reduced their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research report on Monday, May 5th. Morgan Stanley cut their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Finally, Mizuho increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $141.57.

Insider Activity

In related news, Director Andrew A. Krakauer acquired 1,000 shares of the company's stock in a transaction on Tuesday, August 5th. The shares were purchased at an average price of $115.25 per share, for a total transaction of $115,250.00. Following the purchase, the director owned 7,192 shares in the company, valued at $828,878. This represents a 16.15% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jaewon Ryu purchased 1,500 shares of the stock in a transaction dated Tuesday, August 5th. The shares were bought at an average price of $115.00 per share, for a total transaction of $172,500.00. Following the completion of the acquisition, the director owned 3,727 shares in the company, valued at $428,605. This represents a 67.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 5,500 shares of company stock valued at $633,590 in the last three months. 1.40% of the stock is currently owned by insiders.

Teleflex Price Performance

Shares of TFX traded down $0.26 during trading hours on Tuesday, hitting $127.29. 477,949 shares of the company were exchanged, compared to its average volume of 787,642. The firm has a fifty day simple moving average of $118.28 and a 200-day simple moving average of $130.03. The company has a market capitalization of $5.63 billion, a PE ratio of 29.95, a PEG ratio of 1.80 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period last year, the company posted $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be issued a $0.34 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex's dividend payout ratio is currently 32.00%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.